Drug Type Small molecule drug |
Synonyms Tetracaine/benzocaine, CTY-5339, CTY-5339-A + [1] |
Target |
Mechanism Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers), RYR1 modulators(Ryanodine receptor 1 modulators), RYR2 modulators(Ryanodine receptor 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H11NO2 |
InChIKeyBLFLLBZGZJTVJG-UHFFFAOYSA-N |
CAS Registry94-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anesthesia | Phase 2 | US | 07 Dec 2016 | |
Pain | Phase 2 | US | 07 Dec 2016 |
Phase 2 | 75 | (Stage I: One Spray CTY-5339-A) | zxtqfndmxy(vklohyxwcv) = shbabiahba ygayugijlq (izbvwfqkfs, saeeqjgmrb - xljpsmwdah) View more | - | 21 Aug 2019 | ||
One spray CTY-5339-CB (Stage I: One Spray CTY-5339-CB) | zxtqfndmxy(vklohyxwcv) = jxezujbhqb ygayugijlq (izbvwfqkfs, ksnsuysfmb - wjpkslpqtl) View more |